The IRA: Slowing Ambulance Rides to Reduce Wait Times
Provisions in the IRA intend to lower drug costs, yet unintended consequences to this goal will likely cost far more than the money saved.
The IRA: Slowing Ambulance Rides to Reduce Wait Times
The Post-COVID Shift to Patient-Centric Cancer Clinical Trials
Blood-based Biomarkers in Cancer
The Value of Molecularly Defined Patient Advocacy Groups
Decision-making for Cancer Clinical Trial Participants
Four Facets of Ethics in Cancer Clinical Trials
The Patient Journey of People with Cancer